ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0749

Locating Cellular Subsets in Rheumatoid Arthritis Synovium Using CO-Detection by IndEXing (CODEX)

Isabella Wulur1, David Boyle2, Lin Zhang1, Andrea Martin1, Robert Benschop3 and Gary Firestein4, 1Eli Lilly, Indianapolis, IN, 2UC San Diego, San Diego, CA, 3Eli Lilly and Company, Indianapolis, IN, 4University of California, San Diego, La Jolla, CA

Meeting: ACR Convergence 2020

Keywords: Fibroblasts, Synovial, Inflammation, rheumatoid arthritis, Synovitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 7, 2020

Title: RA – Diagnosis, Manifestations, & Outcomes Poster II: Biomarkers

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: To better understand site-of-disease mechanisms in arthritis, the phenotypes and organization of synovial cells and infiltrates are critical. Conventional histology-based approaches are limited in the number of proteins that can be detected and quantification can be difficult due to non-linear detection systems. Tissue disaggregation techniques have advantages for some techniques, but disrupt tissue organization, might not liberate all cell types with equal efficiency and can result in loss of cell surface markers. To address this, we applied a novel multiplex immunofluorescence imaging platform (CODEX) to synovial tissue obtained from patients with rheumatoid arthritis (RA) or osteoarthritis (OA).

Methods: CODEX was performed by simultaneously applying 20 different antibodies, each labeled with a unique tag, to a 6 µm frozen tissue section. This technique was followed by iterative marker imaging, data processing and single cell segmentation to generate high resolution images along with marker intensities of each cell. These were used to create a model of cell phenotype, quantification and spatial organization of all identified cell types.

Results: In our initial analysis of 20 markers, we identified the location of multiple subsets, including macrophages, B cells, T cells and mesenchymal cells (Fig 1A). Signals for individual subsets correlated with standard histology in leukocyte-rich and leukocyte-poor tissue sections. One example of how CODEX can identify phenotypically defined cells was fibroblasts, where 4 distinct phenotypes of putative fibroblasts (CD45-) were defined by combinations of podoplanin, CD90, and CD34 (Fig 1B). Type 1 cells (Fb1; podoplanin+ CD34-, CD90-) are almost exclusively found in the intimal lining, whereas Fb2 (CD90+, CD34-, podoplanin-), Fb3 (CD34+, podoplanin+, CD90-), and Fb4 (CD34+, CD90+, podoplanin-) are all located in the sublining. In our small test cohort (4 RA, 3 OA) we noted a nonsigificant numerical increase in total cells in leukocyte-rich RA vs. OA (4994 vs. 2469 average cells/mm2, respectively).  The percentage of Fb4 cells was numerically higher in leukocyte-rich RA compared with OA (13.6% vs. 7.5%, respectively).

Conclusion: CODEX technology allows the accurate simultaneous spatial mapping of a multiple cellular phenotypes in situ as suggested here by the location of fibroblast subtypes. Future direction includes combining CODEX with transcriptomics to provide additional characterization of potential pathogenic cells in RA.

) Representative CODEX image of RA synovium with CD4 staining in red, CD19 in green, CD68 in yellow, CD90 in cyan, von Willebrand factor (vWF) in magenta and podoplanin in blue. B) Location of 4 distinct phenotypes of putative fibroblasts defined by combinations of podoplanin, CD90, and CD34 expression. Fibroblast type 1 (Fb1) cells are almost exclusively found in the intimal lining, whereas Fb2, Fb3 and Fb4 are all located in the sublining.


Disclosure: I. Wulur, Eli Lilly & Co., 1, 3, 4; D. Boyle, None; L. Zhang, Eli Lilly and Company, 1, 3; A. Martin, Eli Lilly, 3; R. Benschop, Eli Lilly and Company, 1, 3, 4; G. Firestein, Eli Lilly, 2.

To cite this abstract in AMA style:

Wulur I, Boyle D, Zhang L, Martin A, Benschop R, Firestein G. Locating Cellular Subsets in Rheumatoid Arthritis Synovium Using CO-Detection by IndEXing (CODEX) [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/locating-cellular-subsets-in-rheumatoid-arthritis-synovium-using-co-detection-by-indexing-codex/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/locating-cellular-subsets-in-rheumatoid-arthritis-synovium-using-co-detection-by-indexing-codex/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology